Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
SGLT2 drugs
Pharma
Lexicon preps FDA resubmission for diabetes hopeful Zynquista
The company hopes its long and bumpy five-year journey will soon see an end with an FDA approval.
Zoey Becker
Mar 12, 2024 7:15am
Lexicon poaches BMS' Tom Garner as new commercial lead
Oct 10, 2023 9:45am
Lilly, Boehringer's Jardiance gets CKD approval to challenge AZ
Sep 22, 2023 10:05am
Lexicon finally scores FDA nod for heart failure drug Inpefa
May 30, 2023 9:55am
AZ's Forxiga scores expanded heart failure indication in EU
Feb 7, 2023 4:05pm
TheracosBio wins FDA green light for new diabetes med
Jan 23, 2023 9:50am
